184 related articles for article (PubMed ID: 14966583)
1. [Establishment and drug-resistance gene expression of cisplatin-resistant cell line Tca8113/CDDP].
Zhou XJ; Li Q; Chen WT
Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):432-5. PubMed ID: 14966583
[TBL] [Abstract][Full Text] [Related]
2. [Establishment and biological characteristics of cisplatin resistant cell line from human tongue squamous cell carcinoma Tca8113].
Zhou XJ; Chen WT; Li Q; He RG
Shanghai Kou Qiang Yi Xue; 2001 Mar; 10(1):31-4. PubMed ID: 14994074
[TBL] [Abstract][Full Text] [Related]
3. [In vitro gene silencing by siRNA of cyclin D1 on tongue squamous cell carcinoma cell line resistant to cisplatin].
Zhou XJ; Zhang ZY; Zhang P; Pan HY; Chen WT; Ye DX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov; 41(11):646-9. PubMed ID: 17331354
[TBL] [Abstract][Full Text] [Related]
4. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
Yang JX; Luo Y; Qiu HM; Tang WX
Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
[TBL] [Abstract][Full Text] [Related]
5. [Silencing of survivin gene enhances chemosensitivity of human tongue cancer cell line Tca8113 to cisplatin].
Xu JH; Pan CB; Huang HZ; Zhang B; Wang JG; Zhang LT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 May; 42(5):280-3. PubMed ID: 17686279
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of cisplatin-induced metallothionein isoforms in squamous cell carcinoma.
Nakano M; Sogawa CA; Sogawa N; Mishima K; Yamachika E; Mizukawa N; Fukunaga J; Kawamoto T; Sawaki K; Sugahara T; Furuta H
Anticancer Res; 2003; 23(1A):299-303. PubMed ID: 12680227
[TBL] [Abstract][Full Text] [Related]
7. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.
Wang J; Liu X; Jiang W
Chin Med J (Engl); 2000 Oct; 113(10):957-60. PubMed ID: 11775848
[TBL] [Abstract][Full Text] [Related]
8. [The effects of nm23-H1 on metastases ability and chemo-sensitivity in Tca8113 cell lines].
Chen S; Huang H; Pan J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Jun; 21(3):180-3. PubMed ID: 12898755
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
10. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
11. [Reversal effect of hyperthemia on multidrug resistant phenomena].
Zhang P; Wang D; Zheng G
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):127-9. PubMed ID: 12838699
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
Cheng G; Li Y; Tian F
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
[TBL] [Abstract][Full Text] [Related]
13. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.
Gu Y; Fan S; Xiong Y; Peng B; Zheng G; Yu Y; Ouyang Y; He Z
FEBS Lett; 2011 Mar; 585(6):881-7. PubMed ID: 21334329
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
16. Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells.
Toshimitsu H; Hashimoto K; Tangoku A; Iizuka N; Yamamoto K; Kawauchi S; Oga A; Furuya T; Oka M; Sasaki K
Cancer Lett; 2004 Jul; 211(1):69-78. PubMed ID: 15194218
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line.
Saburi Y; Nakagawa M; Ono M; Sakai M; Muramatsu M; Kohno K; Kuwano M
Cancer Res; 1989 Dec; 49(24 Pt 1):7020-5. PubMed ID: 2479474
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of 5 resistant ovarian cancer cell strains and expression of resistance-related genes].
Luan YZ; Li L; Li DR; Zhang W; Tang BJ
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):403-7. PubMed ID: 15312326
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition effect on Tca8113/CDDP by antisense oligonucleotides of cyclin D1 combined with cis diamminedichloroplatinum].
Zhou XJ; Yu Y; Pan HY; Chen WT; Zhang P; Zhang ZY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):354-7. PubMed ID: 16836906
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer.
Wang X; Kong L; Zhao J; Yang P
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):339-43. PubMed ID: 12408759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
